4.5 Article

A rat model established by simulating genetic-environmental interactions recapitulates human Alzheimer's disease pathology

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Acrolein adducts and responding autoantibodies correlate with metabolic disturbance in Alzheimer's disease

Monika Renuka Sanotra et al.

Summary: The formation of aldehydic adducts is associated with metabolic disturbance and the development of Alzheimer's disease. Specific antibodies against aldehydic adducts may play a crucial role in the pathogenesis of both metabolic syndrome and Alzheimer's disease.

ALZHEIMERS RESEARCH & THERAPY (2023)

Article Clinical Neurology

The heritability of amyloid burden in older adults: the Older Australian Twins Study

Rebecca Koncz et al.

Summary: The study found that global amyloid burden has moderate heritability, ranging from 0.20 to 0.54 across different brain regions. There were no significant genetic or environmental correlations between global amyloid burden and markers of small vessel disease.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022)

Article Pharmacology & Pharmacy

Acrolein, an endogenous aldehyde induces Alzheimer's disease-like pathologies in mice: A new sporadic AD animal model

Chen Chen et al.

Summary: The study established a sporadic AD mouse model by gavage administration of acrolein, which effectively exhibited classic pathologies of AD. This model could be crucial for investigating the mechanism of AD onset and developing anti-AD drugs.

PHARMACOLOGICAL RESEARCH (2022)

Review Clinical Neurology

Gene-environment interactions in Alzheimer disease: the emerging role of epigenetics

Lucia Migliore et al.

Summary: Alzheimer's disease (AD) is likely to have a complex etiology involving both genetic and environmental factors. Environmental factors such as diet, lifestyle, alcohol, smoking, and pollutants may interact with genetic factors to induce epigenetic modifications of key AD-associated genes and pathways.

NATURE REVIEWS NEUROLOGY (2022)

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Article Neurosciences

Enhancing GABAergic signaling ameliorates aberrant gamma oscillations of olfactory bulb in AD mouse models

Ming Chen et al.

Summary: The study revealed an increase in gamma oscillations in the olfactory bulb before plaque formation in AD models, along with altered olfactory behavior. This was associated with decreased excitatory responses of M/T cells, reduced GABA release ability, and compensatory increases in GABA(A)R subunit levels. The GABA uptake inhibitor tiagabine showed potential as a therapeutic strategy for early AD symptoms.

MOLECULAR NEURODEGENERATION (2021)

Article Clinical Neurology

White matter hyperintensities and patterns of atrophy in early onset Alzheimer?s disease with causative gene mutations

Chenhui Mao et al.

Summary: White matter hyperintensities can be found in early onset Alzheimer's disease with causative gene mutations. The severity of white matter hyperintensities is related to genotypes and spatial distributions. In early onset AD, more severe atrophy in the posterior cortex than in the medial temporal lobe is observed.

CLINICAL NEUROLOGY AND NEUROSURGERY (2021)

Article Clinical Neurology

2021 Alzheimer's disease facts and figures

[Anonymous]

Summary: Alzheimer's disease has a significant impact on individuals and society as a whole, with a large number of patients in the United States and a potential for continued growth in the future. The value of unpaid caregivers has increased despite a decline in their numbers, and healthcare costs are on the rise. Racial and ethnic disparities in healthcare persist, highlighting the need for greater diversity in dementia care workforce and clinical trials.

ALZHEIMERS & DEMENTIA (2021)

Review Chemistry, Medicinal

Advance of sporadic Alzheimer's disease animal models

Lili Zhang et al.

MEDICINAL RESEARCH REVIEWS (2020)

Article Environmental Sciences

Emerging risk of environmental factors: insight mechanisms of Alzheimer's diseases

Md Ataur Rahman et al.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2020)

Review Biotechnology & Applied Microbiology

Leveraging preclinical models for the development of Alzheimer disease therapeutics

Kimberly Scearce-Levie et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Medicine, Research & Experimental

Immune Response Mechanisms against AAV Vectors in Animal Models

Ashley T. Martino et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Article Multidisciplinary Sciences

The SIGMA rat brain templates and atlases for multimodal MRI data analysis and visualization

D. A. Barriere et al.

NATURE COMMUNICATIONS (2019)

Article Neurosciences

Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease

Han-Hsing Tsou et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Clinical Neurology

Data-driven models of dominantly-inherited Alzheimer's disease progression

Neil P. Oxtoby et al.

Review Neurosciences

White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes

Sara E. Nasrabady et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)

Article Neurosciences

Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories

Marina Avila-Villanueva et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Review Clinical Neurology

Alzheimer's disease: experimental models and reality

Eleanor Drummond et al.

ACTA NEUROPATHOLOGICA (2017)

Review Cell Biology

Brain atrophy in Alzheimer's Disease and aging

Lorenzo Pini et al.

AGEING RESEARCH REVIEWS (2016)

Review Medical Laboratory Technology

Evaluation of dementia by acrolein, amyloid-β and creatinine

Kazuei Igarashi et al.

CLINICA CHIMICA ACTA (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Multimodality Imaging of Alzheimer Disease and Other Neurodegenerative Dementias

Ilya M. Nasrallah et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

Article Neurosciences

Single App knock-in mouse models of Alzheimer's disease

Takashi Saito et al.

NATURE NEUROSCIENCE (2014)

Article Clinical Neurology

Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study

Pearl Behl et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Article Toxicology

Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo

Ying-Juan Huang et al.

TOXICOLOGY LETTERS (2013)

Article Cardiac & Cardiovascular Systems

Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice

Sanjay Srivastava et al.

ATHEROSCLEROSIS (2011)

Review Clinical Neurology

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

Clifford R. Jack et al.

LANCET NEUROLOGY (2010)

Article Biochemistry & Molecular Biology

Potential Role of Acrolein in Neurodegeneration and in Alzheimers Disease

Dang Thanh Nam et al.

Current Molecular Pharmacology (2010)

Review Public, Environmental & Occupational Health

Acrolein environmental levels and potential for human exposure

O. Faroon et al.

TOXICOLOGY AND INDUSTRIAL HEALTH (2008)

Article Biochemical Research Methods

Morris water maze: procedures for assessing spatial and related forms of learning and memory

Charles V. Vorhees et al.

NATURE PROTOCOLS (2006)

Review Biochemistry & Molecular Biology

Lipid peroxidation in aging brain and Alzheimer's disease

TJ Montine et al.

FREE RADICAL BIOLOGY AND MEDICINE (2002)